If you follow the Rheumatology 2.0 link, my article is in the “HEALTH” section on the left. It’s a review of gout treatments.
There is currently moderate quality data supporting the efficacy and safety of allopurinol, febuxostat, benzbromarone, and probenecid in gout. Pegloticase, while efficacious, is associated with more withdrawals due to adverse events and infusion reactions. There is insufficient evidence currently with respect to the cost-effectiveness or the most optimal sequencing of urate-lowering therapy.
Interesting that benzbromarone was more effective than probenecid at lowering uric acid levels, yet it is unavailable in America.